(Q61969376)
Statements
Myfortic® Monotherapy to Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss (English)
0 references
January 2009
0 references
January 2022
0 references
18
0 references
18 year
0 references
70 year
0 references